Clinical Trial Update: Atorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1 [NA]

View source ↗

Summary

A completed clinical trial indicates atorvastatin may mitigate cognitive impairment linked to ischemic white matter lesions and cerebral small vessel disease by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Small Vessel Disease
• Ischemic White Matter Lesions

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: Suzhou Municipal Hospital of Anhui Province | Conditions: Ischemic White Matter Lesions (WMIL), Cerebral Small Vessel Disease | NA | Status: COMPLETED